Evidence map›Paper›PMID 32831060›Full record

ArticleBMC cancer2020

HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.

Hao Zeng, Xindi Song, Jianrui Ji, Linyan Chen, Qimeng Liao, Xuelei Ma

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogens (Basel, Switzerland) · 2023
    Article
  5. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hao ZengDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Alley, Chengdu, 610041, People's Republic of China.
Xindi SongDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Alley, Chengdu, 610041, People's Republic of China.
Jianrui JiDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Alley, Chengdu, 610041, People's Republic of China.
Linyan ChenDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Alley, Chengdu, 610041, People's Republic of China.
Qimeng LiaoDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Alley, Chengdu, 610041, People's Republic of China.
Xuelei MaDepartment of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Alley, Chengdu, 610041, People's Republic of China. drmaxuelei@gmail.com.ORCID http://orcid.org/0000-0002-9148-5001
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHead and neck squamous cell carcinoma (HNSCC) is the sixth most common tumor in human. Research has shown that HPV status HNSCC is a unique prognosis factor, which may due to its immune infiltration landscape. But the underlying mechanism is unclear.

methodsIn this study, we used a combination of several bioinformatics tools, including WCGNA, ssGSEA, CIBERSORT, TIDE,etc., to explore significant genes both related to HPV infection status and immune cell infiltration in HNSCC patients.

resultsCombined with several bioinformatics algorithms, eight hub genes were identified, including LTB, CD19, CD3D, SKAP1, KLRB1, CCL19, TBC1D10C and ARHGAP4. In HNSCC population, the hub genes had a stable co-expression, which was related to immune cell infiltration, especially CD8+ T cells, and the infiltrative immune cells were in a dysfunctional status. Samples with high hub genes expression presented with better response to immune check point block (ICB) therapy and sensitivity to bleomycin and methotrexate.

conclusionsThe eight hub genes we found presented with a stable co-expression in immune cell infiltration of HPV + ve HNSCC population. The co-expression of hub genes related to an immune microenvironment featuring an increase in immune cells but high degree of immune dysfunction status. Patients with high hub gene expression had a better response to ICB treatment, bleomycin and methotrexate. The co-expression of hub genes may be related to immune infiltration status in patients. The concrete molecular mechanism of hub genes function demands further exploration.

Indexed as

AlphapapillomavirusAntineoplastic Combined Chemotherapy ProtocolsBleomycinCD8-Positive T-LymphocytesComputational BiologyDatasets as TopicDrug Resistance, NeoplasmGene Expression ProfilingGene Expression Regulation, NeoplasticHumansImmune Checkpoint InhibitorsLymphocytes, Tumor-InfiltratingMethotrexateOligonucleotide Array Sequence AnalysisPapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckBleomycinImmune Checkpoint InhibitorsMethotrexateGeneHNSCCHPVImmunotherapyTumor microenvironment

Identifiers

PMID32831060
PMCPMC7444264
OpenAlexW3081166292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.